genome analysis
GeneDx Lays off 10 Percent of Staff as Part of $40M Cost Cutting Plan, Secures $75M Debt Financing
The clinical genetic testing company also lowered its revenue guidance for 2023 and reported $53.3 million in revenues for the third quarter.
Euformatics Forms Distribution Partnership for Eastern Europe With Bulgaria's Elta 90
The bioinformatics firm will sell its Genomics Hub software to labs and research institutes in Romania, North Macedonia, and Moldova through a local partner.
Sophia Genetics to Commercialize MSK-ACCESS Clinical Liquid Biopsy Test
The collaboration between Sophia and Memorial Sloan Kettering Cancer Center aims to offer new testing and analytics capabilities to clinicians and researchers.
Variantyx Secures $20M Debt Financing to Support Precision Medicine in North America, Europe
The maker of diagnostic WGS analysis software looks to grow its market share after expanding into oncology and prenatal testing last year.
P4 Diagnostix, Pierian Partner to Offer Somatic Prostate Cancer Testing
The companies will use Illumina's TruSight Oncology 500 cancer panel to complement P4's UroSeq NGS-based germline testing.
May 11, 2022
Mar 25, 2022
Nalagenetics Closes $12.6M Series A Funding Round
Jan 20, 2022
Nov 10, 2021
Geneyx Genomex Closes $6.5M Seed Financing Round
Nov 10, 2021
Sophia Genetics Q3 Revenues Increase 44 Percent
Sep 9, 2021
Sophia Genetics Q2 Revenue Grows 72 Percent
Jul 19, 2021
Sophia Genetics Increases IPO Target to $221M
May 6, 2021
NantHealth Q1 Revenues Decline 11 Percent
Feb 25, 2021